ArticleScientific reports2024
Evaluation of tolvaptan-associated hepatic disorder using different national pharmacovigilance databases.
Takaya Uno et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it